ENDRA Life Sciences Inc. NDRA

Set alert

Price alert · NDRA

All alert types
4.80 USD +0.05 +1.05%

At close · Nov 2

4.79 -0.01 -0.21%

After hours · Nov 2, 4:00 PM ET

Bid
4.70 × 2
Ask
4.90 × 2
4.64 Day range 4.89
2.96 52-week range 6.95
YTD
+5.96%
1 year
-8.57%
Open
4.64
Prev close
4.75
Mkt cap
7.20M
Vol
5.78K
Avg vol
31.14K
EPS
-6.33
P/E
0.00
Div yield
0.00%
More statistics
Low
4.64
High
4.89
Forward P/E
-0.02
Beta
0.74
Short ratio
0.05
Inst. own
0.49%
Dividend
0.00
Ex-div date
50-d avg
6.68
200-d avg
291.96
1y target
2,625.00

5D chart

Chart tools
Interval

Signals (51)
NameTimeAgo
MACD: Sell SignalNov 2, 12:30 PM14 hours ago
SMA: BullishNov 2, 11:35 AM15 hours ago
MACD: Buy SignalNov 2, 11:35 AM15 hours ago
MACD: Sell SignalNov 2, 11:30 AM15 hours ago
SMA: BearishNov 2, 11:00 AM15 hours ago
SMA: BullishNov 2, 10:15 AM16 hours ago
SMA: BullishNov 2, 10:15 AM16 hours ago
MACD: Buy SignalNov 2, 10:15 AM16 hours ago
RSI: OverboughtNov 2, 10:15 AM16 hours ago
MACD: Sell SignalOct 30, 3:45 PM3 days ago
RSI: OversoldOct 30, 3:45 PM3 days ago
MACD: Buy SignalOct 30, 1:40 PM3 days ago
MACD: Sell SignalOct 30, 1:20 PM3 days ago
RSI: OversoldOct 30, 1:20 PM3 days ago
MACD: Buy SignalOct 30, 10:25 AM3 days ago
SMA: BullishOct 30, 10:15 AM3 days ago
SMA: BearishOct 30, 9:35 AM3 days ago
MACD: Sell SignalOct 30, 9:35 AM3 days ago
RSI: OversoldOct 30, 9:35 AM3 days ago
SMA: BearishOct 29, 3:55 PM4 days ago

Newest 20 of 51.

Analyst view

Consensus: none

Price target (mean) 2,625.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

NDRA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-143.50-143.50 – -143.50-297.50+51.8%00.0%1
Next quarter-142.80-142.80 – -142.80-455.00+68.6%00.0%1
Current year-1,661.10-1,661.10 – -1,661.10-2,765.00+39.9%00.0%1
Next year-538.30-538.30 – -538.30-1,661.10+67.6%100.00K0.0%1

Upgrades and downgrades

The latest rating changes

NDRA analyst upgrades and downgrades
DateFirmActionFromTo
Jun 7, 2024Ascendiant CapitalMaintainedBuyBuy
Mar 31, 2023HC Wainwright & Co.Reiterated—Buy